Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × Spironolactone × Clear all

Phase

Phase EARLY_PHASE1 4 Phase NA 3 Phase 2 3 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Heart Failure 1 Cardiotoxicity 1

Interventions

Metformin 44 Dexamethasone 44 Saline Solution 37 Cyclophosphamide 32 Cytarabine 31 Sodium Chloride 30 Bupivacaine 29 Propofol 24 Dexmedetomidine 24 Vincristine 22 Fluorouracil 22 Cisplatin 22 Methotrexate 21 Fentanyl 21 Letrozole 20 Doxorubicin 19 Carboplatin 18 Acetaminophen 17 Morphine 16 Lidocaine 16 Granulocyte Colony-Stimulating Factor 16 Mercaptopurine 15 Etoposide 15 Bevacizumab 15 Sevoflurane 14 Ropivacaine 14 Clomiphene 14 Rituximab 13 Prednisone 13 Oxaliplatin 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06005259 2023-08-22

SPIROTOX

University of Sao Paulo

Phase 4 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡